Drug Channels Institute (DCI) is a leading source of industry research about pharmaceutical economics and the drug distribution system. >

Industry Reports

The 2026 Economic Report on U.S. Pharmacies and Pharmacy Benefit Managers

The ultimate guide to the complex web of interactions within the U.S. prescription distribution and reimbursement system more >

The 2026-27 Economic Report on Pharmaceutical Wholesalers and Specialty Distributors

The most comprehensive tool for analyzing the economic and business realities of the U.S. pharmaceutical distribution industry. more >

From The Drug Channels Blog

BlinkRx Insights: Clarifying the Mystery around “DTP”

Today's guest post comes from Geoff Chaiken, CEO at BlinkRx. Geoff examines the different roles of telemedicine, consumer rebates through cash discount cards, and cash-pay pharmacies in direct-to-patient (DTP) more >

Disintegration: Adam’s Four Takeaways from the CVS Health Breakup

By Adam J. Fein, Ph.D. Despite my impending retirement from DCI, I can’t resist sharing a few thoughts on the news that CVS Health plans to split itself up. more >